The in vitro effects of peptide-precipitating lignosulphonic acids on various biologically active substances produced by or with action on microorganisms.
D000900:Anti-Bacterial Agents / Q000037:antagonists & inhibitors*; D000992:Antitoxins; D001419:Bacteria / Q000187:drug effects*; D001433:Bacteriolysis / Q000187:drug effects; D003087:Colicins / Q000037:antagonists & inhibitors*; D003090:Coliphages / Q000187:drug effects; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004798:Enzymes / Q000097:blood; D005658:Fungi / Q000187:drug effects*; D006460:Hemolysin Proteins / Q000378:metabolism; D066298:In Vitro Techniques; D008031:Lignin / Q000494:pharmacology*; D008244:Lysophosphatidylcholines / Q000037:antagonists & inhibitors*; D008722:Methods; D010740:Phospholipases / Q000037:antagonists & inhibitors; D013451:Sulfonic Acids / Q000494:pharmacology*; D014780:Viruses / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000992:Antitoxins; D003087:Colicins; D004798:Enzymes; D006460:Hemolysin Proteins; D008244:Lysophosphatidylcholines; D013451:Sulfonic Acids; D008031:Lignin; D010740:Phospholipases